Effect of an integral suspension of Lepidium latifolium on prostate hyperplasia in rats

Fitoterapia

Volumn 75, Issue 2, 2004, Pages 187-191

  Martinez Caballero S ^a   Carricajo Fernandez C ^a   Perez Fernandez R ^b  

^a Invest Devmt Innov Ctr Soria N   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Benign prostatic hyperplasia (BHP); Lepidium latifolium

Indexed keywords

LEPIDIUM LATIFOLIUM EXTRACT; PLANT EXTRACT; STEROID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LEPIDIUM; LEPIDIUM LATIFOLIUM; MALE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; STATISTICAL ANALYSIS; STEROID THERAPY;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG ADMINISTRATION SCHEDULE; LEPIDIUM; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR;

LEPIDIUM LATIFOLIUM;

EID: 17144469078     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2003.12.016     Document Type: Article

References (25)

1. O'Brien W.M. Am Fam Physician. 44:1991;162.
2. Tsukamoto T., Masumori N. Int J Urol. 4:(3):1997;233.
3. Cuellar D.C., Kyprianou D. Cur Opin Urol. 11:2001;27.
4. Lee C., Kozlowski J.M., Grayhack J.T. Urol Clin N Am. 22:(2):1995;237.
5. Walsh P.C. Benign prostatic hyperplasia. Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. 6th ed Campbell's urology. 1:1992;1009 WB Saunders, Philadelphia.
6. Lee C. Physiology of castration-induced regression in rat prostate. Murphy G., Sandberb A.A., Karr J.P. The prostatic cell: structure and function. 1981;177 Alan R Liss, New York.
7. Bruchovsky N., Lesser B., Van Doorn E. Vitam Horm. 33:1975;61.
8. Walsh PC. Experimental approaches to benign prostatic hypertrophy: animal models utilizing the dog, rat and mouse. In: Grayhack JT, Wilson HD, Scherbenske MJ editors. Benign prostatic hyperplasia, Washington DC, No Pub (NIH), 1976. pp. 76, 215
9. Lundgren R., Holmquist B., Hesselvik M., Müntzing J. Prostate. 5:1984;277.
10. Cunah G.R., Donjacour A.A., Cooke P.S., Mee S., Gipsby R.M., Higgins S.J., Sugimura Y. Endocr Rev. 8:1987;338.
11. Funke P.J., Tunn U.W., Senge Th., Neumann F. Histological and histochemical findings in prostates of castrated dogs after treatment with estradiol, tamoxifen, androstanodiol and cyproterone acetate. Altwein J.E., Bartsch G., Jacobi G.H. Antihormone-Bedeutung in der Urologie OW. 1981;51 Zuckschwredt Verlag, München.
12. Tunn U.W., Schüring B., Senge Th., Neumann F., Schweikert H.U., Rohr H.P. Investig Urol (Berl). 18:1981;289.
13. Henderson D., Habenicht U.F., Nishino Y., El Etreby M.F. Steroids. 50:1987;1.
14. Chang W.Y., Shidaifat F., Chang C.J.G., Kulp S.K., Sugimoto Y., Canatan H., Brueggemeier R.W., Lin C.Y. Res Commun Mol Pathol Pharmacol. 92:(3):1996;341.
15. McConnell J.D. Urol Clin N Am. 17:1990;661.
16. Paubert-Braquet M., Richardson F.O., Servent-Saez N., Gordon W.C., Monge M.C., Bazan N.G., Authie D., Braquet P. Pharmacol Res. 34:(314):1996;171.
17. Navarro E., Alonso J., Rodriguez R., Trujillo J., Boada J. J Ethnopharmacol. 41:(1-2):1994;65.
18. Font Quer P. Plantas Medicinales. El Discórides renovado. In: Labor SA, editor. Lepidio. 15th edition, Barcelona: 1995. p. 269
19. Le Bail J.C., Laroche T., Marre-Fournier, Habrioux G. Cancer Lett. 133:(1):1998;101.
20. Jeong H.J., Shin Y.G., Kim I.H., Pezzuto J.M. Arch Pharm Res. 22:(3):1999;309.
21. Makela S., Poutanen M., Kostian M.L., Lehtimaki N., Strauss L., Santii R., Vihko R. Proc Soc Exp Biol Med. 217:(3):1998;310.
22. Krazeisen A., Breitling R., Moller G., Adamski J. Mol Cell Endocrinol. 171:(1-2):2001;151.
23. Molnar J., Beladi I., Domonkos K., Foldeak S., Boda K., Veckenstedt A. Neoplasma. 28:(1):1981;11.
24. Elattar T.M., Virji A.S. Anticancer Res. 20:(3A):2000;1733.
25. Robinette C.L. Prostate. 12:1988;271.